This test is not orderable.

OnkoSight NGS AML Panel Build info

Synonyms

  • ONKOSIGHT NGS AML PANEL
  • ACUTE MYELOID LEUKEMIA
  • LAB4138

Short Name

ONKOSIGHT NGS AML PANEL

Procedure Master Number

LAB4138

Procedure ID

189675

Clinical Info

Tumor sequencing by NGS detecting mutations in 30 genes associated with AML. Mutations often have prognostic significance, may confer 
resistance to FDA approved therapies, or may qualify patients for late-stage clinical trials.

Specimen Sources

 Bone Marrow

Specimen Types

 Bone Marrow

Container

Lavender Top Tube

Collection Instructions

Container/Tube: Lavender top tube
Specimen: 2 mL Bone Marrow or Whole Blood
Alternate Specimens: Bone Marrow - Green Top, Peripheral Blood - Lavender Top,
Peripheral Blood - Green Top, Eppendorf tube, Unstained Slide, Formalin-fixed,
Paraffin-embedded Tissue
Decalcified specimens are not recommended for NGS testing.
Note: Please indicate specimen type

Transport Instructions

Room Temperature

Specimen Stability

30 Days Room Temperature or Refrigerated

Methodology

Genotyping by Next Generation Sequencing
Gene:
ASXL1BRAFBCORCEBPACSFR3DDX41DNMT3AETV6EZH2FLT3GATA2HRASIDH1IDH2JAK2KITKMT2AKRASNF1NPM1NRASPDGFRAPHF6PTPN11RUNX1SETBP1STAG2TET2TP53WT

Days Performed

TAT: 10 - 12 Days

Performing Laboratory

GenPath BioReference
Test Code: TL94

CPT

81450

PDM

 1659925

Only Orderable at Locations:

 Orderable Everywhere

Results
Component Name Base Name Common Name External Name
ONCOGENE DX ONCOGENE ONCOGENE DX Oncogene Dx
THERAPEUTIC AND PROGNOSTIC ASSOCIATIONS THERPROGASS THERAPEUTIC AND PROGNOSTIC ASSOCIATIONS Therapeutic And Prognostic Associations
INTERPRETATION SUMMARY INTERP INTERPRETATION SUMMARY Interpretation Summary
DETAILED GENETIC INTERPRETATION 1 DETAILGENINT DETAILED GENETIC INTERPRETATION 1 Detailed Genetic Interpretation 1
DETAILED GENETIC INTERPRETATION 2 : DETAILGENINT DETAILED GENETIC INTERPRETATION 2 Detailed Genetic Interpretation 2 :
CLINICAL TRIALS 1 : CLINTRIAL CLINICAL TRIALS 1 Clinical Trials 1 :
CLINICAL TRIALS 2 : CLINTRIAL CLINICAL TRIALS 2 Clinical Trials 2 :
TECHNICAL SUMMARY : TECHSUM TECHNICAL SUMMARY Technical Summary :
METHODS METHODS METHODS Methods
REFERENCES 1 REF1 REFERENCES 1 References 1
REFERENCES 2 REF2 REFERENCES 2 References 2
REPORT FOOTER RPTFOOTER REPORT FOOTER Report Footer
ADDENDUM : ADDENDUM ADDENDUM
ALLELE FREQUENCIES: ALLELE ALLELE FREQUENCIES Allele Frequencies: